Incidence, Clinical Characteristics and Outcome of Unexpected Uterine Sarcoma after Hysterectomy for Uterine Mass: A Retrospective Study of 774 Cases

Authors

  • Monika Jindal

Keywords:

laparoscopy, morcellation, uterine sarcoma, uterine fibroid, hysterectomy

Abstract

Background: Women often require a hysterectomy via laparotomy or laparoscopy. Morcellation is often necessary to perform a laparoscopic surgery. The objective of this study is to determine the incidence of unexpected uterine sarcomas (UUSs) after hysterectomy and to reduce the occurrence and avoid the morcellation of UUSs by analyzing their characteristics. Methods: Women who had a hysterectomy for various reasons in Chandulal Chandrakar Memorial Medical College, Durg, India between January 2014 and September 2016 were selected for the study, and their clinical characteristics were analyzed. Results: During the period, 5 UUSs were found in 774 cases, and the overall incidence was 0.65%. Most of the UUSs were stage I (80%), which occurred more commonly (80%) in women aged 40–49. Abnormal uterine bleeding (60%) was the main clinical manifestation. The margins of most UUSs (80%) were regular, which may cause UUSs to be misdiagnosed as uterine fibroids. Conclusion: The incidence of UUSs after hysterectomy for uterine fibroids was low, and their clinical characteristics are atypical. It is necessary and very critical to make a complete and cautious preoperative evaluation to reduce the occurrence and avoid the morcellation of UUSs.

How to Cite

Incidence, Clinical Characteristics and Outcome of Unexpected Uterine Sarcoma after Hysterectomy for Uterine Mass: A Retrospective Study of 774 Cases. (2017). Global Journal of Medical Research, 17(15), 29-32. https://medicalresearchjournal.org/index.php/GJMR/article/view/

References

Nieboer TE, Johnson N, Lethaby A (2009) Surgical approach to hysterectomy for benign gynaecological disease. (3), CD003677.

B. Sehnal, D. Driak, E. Kmonickova (2011) Current classification of malignant tumours in gynecological oncology - part I Ceska Gynekol. 76(4), 279-284.

B. Sehnal, D. Driak, E. Kmonickova (2011) Current classification of malignant tumours in gynecological oncology - part II Ceska Gynekol. 76(5), 360-366.

Einstein MH, Barakat RR, Chi DS (2008) Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease Int J Gynecol Cancer. 18(5), 1065-1070. https://doi.org/10.1111/j.1525-1438.2007.01126.x

Oduyebo T, Rauh-Hain AJ, Meserve EE (2014) The value of re-exploration in patients with inadvertently morcellated uterine sarcoma Gynecol Oncol. 132(2), 360-365. https://doi.org/10.1016/j.ygyno.2013.11.024

Beatrice Seddon, Reena Davda (2011) Uterine sarcomas - recent progress and future challenges Eur J Radiol. 78(1), 30-40. https://doi.org/10.1016/j.ejrad.2010.12.057

Null- Wu, Tzu-Chen Yen, Chyong-Huey Lai (2011) Clinical presentation and diagnosis of uterine sarcoma, including imaging Best Pract Res Clin Obstet Gynaecol. 25(6), 681-689. https://doi.org/10.1016/j.bpobgyn.2011.07.002

FDA (2014) Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication. Available from:. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm393576.htm

George S, Barysauskas C, Serrano C (2014) Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma Cancer. 120(20), 3154-3158. https://doi.org/10.1002/cncr.28844

Morice P, Rodriguez A, Rey A (2003) Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients. 24(3-4), 237-240.

Cusido M, Fargas F, Baulies S (2015) Impact of surgery on the evolution of uterine sarcomas J Minim Invasive Gynecol. 22(6), 1068-1074. https://doi.org/10.1016/j.jmig.2015.05.024

Jeong-Yeol Park, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam (2011) The impact of tumor morcellation during surgery on the outcomes of patients with apparently early lowgrade endometrial stromal sarcoma of the uterus Ann Surg Oncol. 18(12), 3453-3461. https://doi.org/10.1245/s10434-011-1751-y

Park JY, Park SK, Kim DY (2011) The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma Gynecol Oncol. 122(2), 255-259. https://doi.org/10.1016/j.ygyno.2011.04.021

Angiolo Gadducci, Stefania Cosio, Antonella Romanini, Andrea Genazzani (2008) The management of patients with uterine sarcoma: a debated clinical challenge Crit Rev Oncol Hematol. 65(2), 129-142. https://doi.org/10.1016/j.critrevonc.2007.06.011

Tamar Perri, Jacob Korach, Siegal Sadetzki, Bernice Oberman, Eddie Fridman, Gilad Ben-Baruch (2009) Uterine leiomyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer. 19(2), 257-260. https://doi.org/10.1111/igc.0b013e31819a1f8f

Brohl AS, Li L, Andikyan V (2015) Age-strati ed risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma. 20(4), 433-439. https://doi.org/10.1634/theoncologist.2014-0361

Pedro Santos, Teresa Cunha (2015) Uterine sarcomas: clinical presentation and MRI features Diagn Interv Radiol. 21(1), 4-9. https://doi.org/10.5152/dir.2014.14053

Mayumi Takeuchi, Kenji Matsuzaki, Masafumi Harada (2013) Preliminary observations and clinical value of lipid peak in highgrade uterine sarcomas using in vivo proton MR spectroscopy Eur Radiol. 23(9), 2358-2363. https://doi.org/10.1007/s00330-013-2856-4

Thomassin-Naggara I, Dechoux S, Bonneau C (2013) How to differentiate benign from malignant myometrial tumours using MR imaging Eur Radiol. 23(8), 2306-2314. https://doi.org/10.1007/s00330-013-2819-9

Wright JD, Tergas AI, Cui R (2015) Use of electric power morcellation and prevalence of underlying cancer in women who undergo myomectomy JAMA Oncol. 1(1), 69. https://doi.org/10.1001/jamaoncol.2014.206

W. Parker, Y. Fu, J. Berek (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma Obstet Gynecol. 83(3), 414-418.

Takamizawa S, Minakami H, Usui R (1999) Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas Gynecol Obstet Invest. 48(3), 193-196. https://doi.org/10.1159/000010172

Juliane Theben, Alexander Schellong, Christopher Altgassen, Katharina Kelling, Stephanie Schneider, Dietmar Große-Drieling (2013) Unexpected malignancies after laparoscopicassisted supracervical hysterectomies (LASH): an analysis of 1,584 LASH cases Arch Gynecol Obstet. 287(3), 455-462. https://doi.org/10.1007/s00404-012-2559-0

Jiaren Zhang, Junji Zhang, Yi Dai, Lan Zhu, Jinghe Lang, Jinhua Leng (2015) Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy Int J Gynaecol Obstet. 130(2), 195-199. https://doi.org/10.1016/j.ijgo.2015.01.009

Graebe K, Garcia-Soto A, Aziz M (2015) Incidental power morcellation of malignancy: a retrospective cohort study Gynecol Oncol. 136(2), 274-277. https://doi.org/10.1016/j.ygyno.2014.11.018

McKenna JB, Kanade T, Choi S (2014) The Sydney contained in bag morcellation technique J Minim Invasive Gynecol. 21(6), 984-985. https://doi.org/10.1016/j.jmig.2014.07.007

Aarathi Cholkeri-Singh, Charles Miller (2015) Cholkeri-Singh A, Miller CE. Power morcellation in a specimen bag. 22(2), 160. https://doi.org/10.1016/j.jmig.2014.10.012

Incidence, Clinical Characteristics and Outcome of Unexpected Uterine Sarcoma after Hysterectomy for Uterine Mass: A Retrospective Study of 774 Cases

Published

2017-07-07

How to Cite

Incidence, Clinical Characteristics and Outcome of Unexpected Uterine Sarcoma after Hysterectomy for Uterine Mass: A Retrospective Study of 774 Cases. (2017). Global Journal of Medical Research, 17(15), 29-32. https://medicalresearchjournal.org/index.php/GJMR/article/view/